• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

ADM Invests in Further Global Growth of Natural Citrus Offerings with Acquisition of the Ziegler Group

Share:

March 18, 2019

Archer Daniels Midland Company announced today that it has reached an agreement to acquire the Ziegler Group, a leading European provider of natural citrus flavor ingredients. The agreement comes shortly after ADM completed its addition of U.S.-based citrus flavor provider Florida Chemical.

“Ziegler is highly respected as a cutting-edge leader in citrus, and we’re excited to welcome their outstanding leadership and talent to ADM,” said Vince Macciocchi, president of ADM’s Nutrition business. “The combination of Ziegler and Florida Chemical will immediately position ADM for growth as a global leader in natural citrus ingredients, with a complete range of innovative citrus solutions and systems for food, beverage and fragrance customers.”

Founded in 1963, Ziegler uses proprietary cold concentration technologies to produce natural high-quality citrus oils, extracts, concentrates and compounds for flavor, food, and beverage industry customers, focusing on Europe, the U.S. and Japan. The company is privately held and headquartered in Aufsess, in southern Germany.

“We are delighted that we found a strong home at ADM where both our business and our people can grow,” said Günter Ziegler. “The integration of more than 50 years of citrus expertise into the ADM group will secure our top priority: successful long-term growth for our business and our employees. Our family members will be staying with the company to help ensure a smooth transition. We’re excited to join ADM and strongly believe that the combination of our technology and citrus capabilities, coupled with the portfolio of ingredients and global reach of ADM, will accelerate growth opportunities while creating benefits for our customers.”

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

“Citrus is one of the fastest-growing, highest-demand flavors for food and beverages, which is why the creation of a global citrus platform offering a complete product line for our customers is such an important capability for our growth strategy,” Macciocchi continued. “We’re continuing the most ambitious portfolio transformation in our company’s long history, and as we build the world’s leading nutrition company, the beneficiaries will be our customers and our shareholders.”

The deal, which is subject to regulatory approval, is expected to close in the second quarter of 2019.

Date: March 18, 2019

Source: Yahoo Finance

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Igenomix Expands Its Presence In North America With The Acquisition Of Access Genomics CanadaIgenomix Expands Its Presence In North America With The Acquisition Of Access Genomics Canada
  • One Rock Capital Partners Completes Acquisition of InnophosOne Rock Capital Partners Completes Acquisition of Innophos
  • Bronchiolitis Drugs Market Expected to Witness High Growth Over the Forecast to 2027Bronchiolitis Drugs Market Expected to Witness High Growth Over the Forecast to 2027
  • German Health Insurance Group Launches Startup Fund for Digital Health InnovationGerman Health Insurance Group Launches Startup Fund for Digital Health Innovation
  • Faro Health Secures $20M to Streamline Smart Clinical TrialsFaro Health Secures $20M to Streamline Smart Clinical Trials
  • Clearwater medical manufacturer sells business segment that made its name famous in surgical suitesClearwater medical manufacturer sells business segment that made its name famous in surgical suites
  • Cellex Becomes First Company to Land FDA Emergency Use Authorization for COVID-19 Serology TestingCellex Becomes First Company to Land FDA Emergency Use Authorization for COVID-19 Serology Testing
  • Mesa Labs Announces Agreement to Acquire Agena Bioscience, Inc.Mesa Labs Announces Agreement to Acquire Agena Bioscience, Inc.

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications